Evidence map›Paper›PMID 29606357›Full record

ArticleJournal of pediatric urology2018

Who, where, and why are patients lost to follow-up? A 20-year study of bladder exstrophy patients at a single institution.

Emily Haddad, Ahmet Ali Sancaktutar, Blake W Palmer, Christopher Aston, Bradley P Kropp

Open access · greenAbstract read
In one paragraph

Article in Journal of pediatric urology, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed, 1 pooled it
0.8field-weighted citation impact, top 28% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed, 1 synthesis or guideline pooled it, 8 citations in OpenAlex.

  1. Pooled it
  2. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

5 authors at 2 institutions in 1 country.

Emily HaddadCook Children's Health Care System, Fort Worth, TX, USA; Department of Urology, University of Oklahoma Health Sciences Center, Oklahoma City, OK, USA. Electronic address: emily.haddad@cookchildrens.org.
Ahmet Ali SancaktutarDepartment of Urology, University of Oklahoma Health Sciences Center, Oklahoma City, OK, USA.
Blake W PalmerCook Children's Health Care System, Fort Worth, TX, USA; Department of Urology, University of Oklahoma Health Sciences Center, Oklahoma City, OK, USA.
Christopher AstonDepartment of Urology, University of Oklahoma Health Sciences Center, Oklahoma City, OK, USA.
Bradley P KroppCook Children's Health Care System, Fort Worth, TX, USA; Department of Urology, University of Oklahoma Health Sciences Center, Oklahoma City, OK, USA.
Cook Children's Health Care System · USUniversity of Oklahoma Health Sciences Center · US

Funding

Tracking and Evaluation CoreU54GM104938 · NIGMS · UNIVERSITY OF OKLAHOMA HLTH SCIENCES CTR · PI PAUL G SPICER · 2013 to 2026
$68.2M
NIGMS NIH HHS U54 GM104938
6 · The paper itself

Abstract

introductionIndividuals with bladder and cloacal exstrophy are at increased risk for kidney disease, renal failure, and bladder complications. Given the social implications and sensitive nature of the disease, these patients are also at risk for psychosocial problems. Lack of regular medical follow-up visits may pose serious risks to their long-term health status. The aim of this study is determine what factors place an affected individual at risk for limited long term follow up. MATERIALS AND

methodsWe identified all patients with bladder or cloacal exstrophy seen by the pediatric urology department at the Oklahoma University Health Sciences Center (OUHSC) between January 1996 and August 2016. Patient data included demographics, insurance coverage, distance from patient's home to the clinic, medical and surgical history, and the date of their last clinic visit. Two groups for comparison were (1) those that had been seen within the last 2 years, and (2) those that were counted as failing to maintain follow-up because 2 or more years had passed since their last clinic visit. These groups were compared using the Student t-test, the chi-square test, or the Fisher exact test and p < 0.05 was treated as significant for the purposes of discussion. RESULTS AND DISCUSSION: Ninety-one patients with bladder or cloacal exstrophy were seen by the pediatric urology department between January 1996 and August 2016. Of the 91 patients, 24 left the clinic for known reasons thus leaving 67 patients that were considered for analyses: 51 had been seen within the last 2 years while 16 were counted as lost to follow-up. These two groups (active and lost to follow-up) did not differ significantly for age at last clinic visit, distance between family's home and clinic, history of bladder reconstruction, sex, or insurance status. There was a significant difference between the two groups in the medical complexity of their condition. The group active in urological care had more patients with cloacal exstrophy and additional anomalies than the group lost to follow-up.

conclusionsPatients with bladder exstrophy and cloacal exstrophy are less likely to maintain annual follow-up visits with their urologist if they have a simpler diagnosis requiring fewer surgical interventions. For patients with exstrophy, regular clinic visits prioritizing education and psychosocial support may prevent hospitalizations, emergency interventions, and poor overall health outcomes. To maintain contact with the medical team and promote optimal health outcomes, a social worker or care coordinator/educator may play an integral part in addressing the unique needs of this population.

Indexed as

ForecastingAdolescentBladder ExstrophyFemaleFollow-Up StudiesHumansLost to Follow-UpMaleOffice VisitsPlastic Surgery ProceduresRetrospective StudiesRisk FactorsUrinary BladderUrologic Surgical ProceduresBladder exstrophyCloacal exstrophyFollow-up clinic visitsPatients lost to follow-up

Identifiers

PMID29606357
PMCPMC9473296
OpenAlexW2791921698

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.